Search for: "Pharmaceutical Generic Developers, Inc." Results 1 - 20 of 1,121
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
[John Ross] Short Circuit: A Roundup of Recent Federal Court Decisions
17 May 2024, 1:07 pm by John Ross
On the other, it encourages generic pharmaceutical manufacturers to challenge name-brand patents while antitrust law prohibits anticompetitive deals. [read post]
The Volokh Conspiracy - http://www.volokh.com/
The FTC Office of Patent Invalidation
6 May 2024, 8:26 am by Daniel J. Gilman
We don’t want to impugn good patents or heap undue costs on firms that develop useful pharmaceuticals. [read post]
Truth on the Market - http://truthonthemarket.com/
McKesson May Change How AKS-Based FCA Claims Are Pled
1 May 2024, 1:18 pm by Melissa Tremblay
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
Whistleblower Blog and News - https://www.whistleblowerllc.com/blog-news/
Regeneron Accused of Drug Pricing Fraud in Latest FCA Case
24 Apr 2024, 4:52 am by Erica Blachman Hitchings
According to a recent press release, the Department of Justice has filed a Complaint against New York-based Regeneron Pharmaceuticals Inc. [read post]
Whistleblower Blog and News - https://www.whistleblowerllc.com/blog-news/
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors
16 Apr 2024, 8:42 am by Holman
Inc. v. [read post]
Patently-O - https://patentlyo.com
Federal Income Taxation of Intellectual Property Development and Cost Recovery
9 Apr 2024, 2:56 pm by Brian Clark
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
Dollars & Sense - https://dollarsandsense.grayreed.com/
Munsingwear Mootness in Sumitomo Pharma v. Vidal
8 Apr 2024, 9:47 am by Dennis Crouch
USA, Inc., No. 2022-1258 (Fed. [read post]
Patently-O - https://patentlyo.com
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA
3 Apr 2024, 1:07 pm by Bevin Newman
Both brand name and generic pharmaceutical and medical device manufacturers should be aware of these developments. [read post]
Antitrust Law Blog - http://www.antitrustlawblog.com/
Recent Delaware Coverage Decisions on Relatedness Leaves D&O Claim Uncertainties
1 Apr 2024, 12:14 pm by Michael S. Levine, Geoffrey B. Fehling and Andrew S. Koelz
Recent guidance from the Delaware Supreme Court moved away from the fundamentally-identical standard in favor of a stricter adherence to policy language governing relatedness, but the recent Delaware Superior Court decision in Alexion Pharmaceuticals, Inc. v. [read post]
Hunton Insurance Recovery Blog - https://www.huntoninsurancerecoveryblog.com/
Obviousness and Pharmaceutical Method of Treatment Claims
1 Apr 2024, 10:58 am by Dennis Crouch
Janssen Pharms., Inc. v. [read post]
Patently-O - https://patentlyo.com
Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 3 . . . and PART 3½)
13 Mar 2024, 7:24 pm by Kurt R. Karst
The PTE application states “[u]nder the terms of the AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION LICENSE AGREEMENT between Pfizer Inc. and OPKO Ireland Ltd. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Trademark Use in the U.S.
29 Feb 2024, 5:54 am by Marc Misthal
Hi-Tech Pharmaceuticals, Inc. sought to register EXPERIMENTAL AND APPLIED SCIENCES as a trademark for use in connection with dietary and nutritional supplements. [read post]
New Jersey Property Management Blog - https://www.offitkurman.com/resources/legal-blog/
California Court of Appeal, Gary Garner v. BNSF Railway Company, Docket No. D082229
28 Feb 2024, 2:00 pm
Kirby Inland Marine Inc. (5th Cir. 2007) 482 F.3d 347, 351.) [read post]
Frederic Borel - http://fredericborel.blogspot.ch/
The Taxman, Technology Litigation and Cavalier Settlement Structures
20 Feb 2024, 4:56 pm by Brian Clark and Joshua Smeltzer
In Acqis Technology, Inc. v. [read post]
Dollars & Sense - https://dollarsandsense.grayreed.com/
Obviousness: Is a Reasonable Expectation of Success Sufficient
19 Feb 2024, 12:55 pm by Dennis Crouch
  Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
Patently-O - https://patentlyo.com
Guest Post: Flipping the Script on the New Excess Health Plan Fee Case Against Johnson & Johnson
12 Feb 2024, 6:07 am by Kevin LaCroix
  This alleged mismanagement caused the plans and their beneficiaries to vastly overpay for generic-specialty drugs [read post]
The D & O Diary - http://www.dandodiary.com/
Are Non-Traded REITs a Safe Bet?
25 Jan 2024, 6:06 pm by The White Law Group
  EQT Exeter: EQT Exeter Real Estate Income Trust  Investment Focus: Stabilized, income-oriented U.S. commercial real estate, primarily targeting supply chain industrial properties and offices leased to research and development tenants in healthcare, biotech, and pharmaceuticals. [read post]
The White Law Group's Securities Fraud Blog - http://www.whitesecuritieslaw.com/securities-fraud/blog/
Health Care Provider Risks When Ordering and Billing Chelation Therapy Services
25 Jan 2024, 5:31 am by Ashley Morgan
Several generic forms of deferoxamine have been approved by the FDA. 1991. [read post]
Liles Parker PLLC Blog - http://www.lilesparker.com
ISS Discusses Largest Securities-Related Class Action Settlements of 2023
23 Jan 2024, 9:01 pm by renholding
The drug price-fixing conspiracy – which became the focus of investigations by the Department of Justice, 49 state attorney generals, and Congress– has embroiled the generic pharmaceutical industry. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/
En Banc Denied in In re Cellect: Double Patenting and Patent Term Adjustment
22 Jan 2024, 1:16 pm by Dennis Crouch
Lewis – Foley Hoag LLP Inari Agriculture, Inc. [read post]
Patently-O - https://patentlyo.com